Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) (PA-24-179)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) (PAR-24-110)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required) (PAR-24-168)

Sponsor: National Center for Complementary and Integrative Health, National Institute on Aging

Award: This R34 is limited to direct costs requests of up to $450,000 over the entire project period. Although variations from year to year are permissible, in no case may any year be more than $225,000 in direct costs. The maximum project period is 3 years.

Due Date: Multiple due dates; see announcement.

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) (PA-24-184)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) (PA-24-185)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required) (PA-24-186)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS ADRD Awardees (NOT-NS-24-071)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Due Date: Notice expires February 15, 2027.

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-24-023)

Sponsor: National Center for Advancing Translational Sciences (NCATS)

Award: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: Multiple due dates; see announcement.

The Alzheimer's Drug Discovery Foundation (ADDF) Therapeutics Funding Programs

Sponsor: The Alzheimer's Drug Discovery Foundation (ADDF)

Due Date: Multiple due dates; see announcement.

Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) (PAR-24-137)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Maximizing Access to Research Careers (MARC) (T34) (PAR-24-138)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

NINDS Program Project Grant (P01 Clinical Trial Optional) (PAR-24-169)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) (PAR-24-161)

Sponsor: National Institutes of Health

Award: Direct costs are limited to $275,000 over the two-year project period. No more than $200,000 in direct costs are allowed in any single year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) (RFA-MH-25-110)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) (RFA-NS-24-016)

Sponsor: National Institutes of Health

Award: Applicants must not exceed $500,000 in direct costs per year for the UG3 phase and should rarely exceed $1,500,000 direct costs per year for the UH3 phase.

Due Date: Multiple due dates; see announcement.